Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

Go back to Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
(NASDAQ: FENC) Delayed: 9.53 +0.47 (5.19%)
Previous Close $9.06    52 Week High
Open $9.44    52 Week Low
Day High $9.53    P/E N/A 
Day Low $9.12    EPS
Volume 443,668       

Forest Laboratories (NYSE: FRX) Delayed: 12.00 --0 (-0%)
Previous Close $12.00    52 Week High $100.88 
Open $24.87    52 Week Low $64.33 
Day High $12.00    P/E 20.69 
Day Low $12.00    EPS $0.58 
Volume 20